The prescribing information notes that gastrointestinal adverse effects are the most common reasons for treatment discontinuation
Side effects that seemed challenging at week 9 have typically faded by week 17
Concentration is a ratio of drug to liquid, so the volume of diluent directly sets how many milligrams end up in a given volume of solution
Three things make PDRN a strong alternative for users disappointed by copper peptides: It signals regeneration through a different pathway, so it does not produce the same inflammatory adjustment phase that drives the copper uglies It has fewer documented interactions with other actives, which makes it easier to fit into an existing routine It is generally well tolerated even by sensitive skin, and pregnancy precautions are less restrictive (though pregnant or breastfeeding users should still consult a doctor before adding any new active) The people who tend to do well on PDRN after a bad copper peptide experience usually fit one of three profiles: sensitive-skin users who could never tolerate the copper uglies, users who want regenerative benefits without managing strict layering rules, and users whose primary concern is repair and resilience rather than aggressive remodelling
Outcomes may vary based on the individual, and users are encouraged to speak with a qualified healthcare professional before beginning any new health program, especially if managing preexisting conditions
Notice the highlighted cells in the 5mg/mL and 10mg/mL columns
